HALAS GUS D has filed 9 insider transactions across 1 company since December 2022.
Most recent transaction: a option exercise of 10061 shares of OptimizeRx Corp ($OPRX) on June 05, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2024 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Common Stock | 10061 | $0.00 | 80,926.0000 | 19,921,879 | 14.20% | 0.05% |
| June 5, 2024 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Restricted Stock Units | 10061 | $0.00 | 0.0000 | 19,921,879 | 100.00% | 0.05% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Common Stock | 4637 | $0.00 | 70,865.0000 | 0 | 7.00% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Restricted Stock Units | 4637 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | A | Restricted Stock Units | 10061 | $0.00 | 10,061.0000 | 0 | 9999.99% | 0.00% |
| March 30, 2023 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Common Stock | 657 | $0.00 | 66,228.0000 | 0 | 1.00% | 0.00% |
| March 30, 2023 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Restricted Stock Units | 657 | $0.00 | 657.0000 | 0 | 50.00% | 0.00% |
| Dec. 30, 2022 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Common Stock | 409 | $0.00 | 65,571.0000 | 0 | 0.63% | 0.00% |
| Dec. 30, 2022 | OptimizeRx Corp | $OPRX | HALAS GUS D | Director | M | Restricted Stock Units | 409 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |